CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Novartis Pharmaceuticals Corporation recalls Diovan (valsartan) 160 mg

Read the official FDA notice

Published
19 Aug 2026
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34

Brand / company
Novartis Pharmaceuticals Corporation
Codes / lots
Lot AV5913C, Expiry: 6/2027
Distribution
US Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 19 Aug 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.